A phase II, randomized trial using the small molecule tyrosine kinase inhibitor lapatinib as a first-line treatment in patients with FISH positive advanced or metastatic breast cancerHenry Gómez, G. W. Sledge, Miguel A. Chavez et al.|Journal of Clinical Oncology|2005Cited by 72
Suppression of C6 Gliomas via Application of Rat Hyperplasia GenePeng Gao, William W. N. Tsang, Hui Guo et al.|The International Journal of Biological Markers|2014Cited by 3